(Q39387888)

11 September 2017

Long-term management of noncancer pain with transdermal therapeutic system-fentanyl (English)

1 reference

Anesthesiology and pain medicine

11 September 2017

0 references

0 references

1 reference

https://api.crossref.org/works/10.1016/S1526-5900(03)00632-1

2 April 2024

1 reference

https://api.crossref.org/works/10.1016/S1526-5900(03)00632-1

2 April 2024

1

Kyriaki Mystakidou

1 reference

11 September 2017

Efi Parpa

2

1 reference

11 September 2017

Eleni Tsilika

3

1 reference

11 September 2017

Athina Mavromati

4

1 reference

11 September 2017

Vassilios Smyrniotis

5

1 reference

11 September 2017

Stavroula Georgaki

6

1 reference

11 September 2017

Lambros Vlahos

7

1 reference

11 September 2017

language of work or name

1 reference

1 August 2003

1 reference

full work available at URL

11 September 2017

https://api.elsevier.com/content/article/PII:S1526590003006321?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S1526-5900(03)00632-1

https://api.elsevier.com/content/article/PII:S1526590003006321?httpAccept=text/plain

2 April 2024

1 reference

https://api.crossref.org/works/10.1016/S1526-5900(03)00632-1

2 April 2024

1 reference

11 September 2017

4

1 reference

11 September 2017

6

1 reference

11 September 2017

298-306

1 reference

Transdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy, and quality of life. The TTS-Fentanyl Comparative Trial Group

11 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900632-1

7 January 2021

Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900632-1

7 January 2021

Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain.

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900632-1

7 January 2021

Pain due to peripheral nerve damage: an hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900632-1

7 January 2021

Dose-response relationship of opioids in nociceptive and neuropathic postoperative pain

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900632-1

7 January 2021

Prolonged treatment with transdermal fentanyl in neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900632-1

7 January 2021

Randomised double-blind active-placebo-controlled crossover trial of intravenous fentanyl in neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900632-1

7 January 2021

Clinical pharmacokinetics of transdermal opioids: focus on transdermal fentanyl

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900632-1

7 January 2021

Outcome of chronic opioid therapy for non-cancer pain

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900632-1

7 January 2021

Morphine responsiveness of chronic pain: double-blind randomised crossover study with patient-controlled analgesia

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900632-1

7 January 2021

Morphine differentially affects the sensory and affective pain ratings in neurogenic and idiopathic forms of pain.

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900632-1

7 January 2021

Transdermal fentanyl: clinical pharmacology.

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900632-1

7 January 2021

Association of pain relief with drug side effects in postherpetic neuralgia: a single-dose study of clonidine, codeine, ibuprofen, and placebo

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900632-1

7 January 2021

Intravenous fentanyl kinetics.

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900632-1

7 January 2021

Comparison of the efficacy and safety of tropisetron, metoclopramide, and chlorpromazine in the treatment of emesis associated with far advanced cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900632-1

7 January 2021

Use of TTS fentanyl as a single opioid for cancer pain relief: a safety and efficacy clinical trial in patients naive to mild or strong opioids

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900632-1

7 January 2021

Greek brief pain inventory: validation and utility in cancer pain

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900632-1

7 January 2021

Long-term observations of patients receiving transdermal fentanyl after a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900632-1

7 January 2021

Quality of life and cancer pain: satisfaction and side effects with transdermal fentanyl versus oral morphine

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900632-1

7 January 2021

Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900632-1

7 January 2021

Physicians' attitudes and practices regarding the long-term prescribing of opioids for non-cancer pain

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900632-1

7 January 2021

A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity

1 reference

https://api.crossref.org/works/10.1016%2FS1526-5900%2803%2900632-1

7 January 2021

Ethical issues in the management of chronic nonmalignant pain

23

1 reference

https://api.crossref.org/works/10.1016/S1526-5900(03)00632-1

Chronic opioid therapy in nonmalignant pain

2 April 2024

26

1 reference

https://api.crossref.org/works/10.1016/S1526-5900(03)00632-1

Use of opioids in non-cancer pain

2 April 2024

28

1 reference

https://api.crossref.org/works/10.1016/S1526-5900(03)00632-1

2 April 2024

Identifiers

1 reference

11 September 2017

1 reference